OLMA   $13.65  0.37% Market Closed After Close 13.64 -0.07%

Olema Pharmaceuticals Inc
Total Cash 239.10M
totalCashPerShare 4.178
EBITDA -122.27M
Total Debt 1.96M
quickRatio 9.042
currentRatio 9.127
Total Revenue
debtToEquity 0.864
Revenue/Share
ROA -0.35467
ROE -0.564
grossProfits
freeCashflow -44.97M
operatingCashflow -92.27M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 489.63M
forwardPE -4.70229
floatShares 29.25M
sharesOutstanding 57.27M
sharesShort 8.84M
sharesShortPriorMonth 8.04M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.04%
heldPercentInstitutions 1.00%
Short Ratio help_outline 13.59%
shortPercentOfFloat 0.27%
impliedSharesOutstanding
bookValue 3.971
Price To Book help_outline 3.10
earningsQuarterlyGrowth
netIncomeToCommon -109.63M
trailingEps -2.04%
forwardEps -2.62%
enterpriseToEbitda -4.00
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.58 3Q 2024
institutionsCount 187
lastUpdated Sept. 16, 2024, 8:06 p.m.